Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.39B | 1.91B | 1.81B | 2.27B | 1.53B |
Gross Profit | 919.92M | 737.05M | 696.64M | 861.32M | 554.26M |
EBITDA | 572.61M | 391.40M | 435.03M | 661.40M | 446.14M |
Net Income | 399.71M | 280.30M | 254.22M | 437.75M | 312.77M |
Balance Sheet | |||||
Total Assets | 3.82B | 3.17B | 2.97B | 2.89B | 2.43B |
Cash, Cash Equivalents and Short-Term Investments | 1.14B | 728.80M | 720.69M | 833.70M | 846.85M |
Total Debt | 438.19M | 415.41M | 374.87M | 197.63M | 175.33M |
Total Liabilities | 1.64B | 1.33B | 1.36B | 1.44B | 1.04B |
Stockholders Equity | 2.17B | 1.84B | 1.61B | 1.44B | 1.38B |
Cash Flow | |||||
Free Cash Flow | 808.91M | 261.73M | 85.54M | 727.92M | 565.69M |
Operating Cash Flow | 848.61M | 328.46M | 136.27M | 736.60M | 579.84M |
Investing Cash Flow | -265.06M | -70.41M | -3.00M | -273.91M | -99.75M |
Financing Cash Flow | -329.07M | -250.59M | -240.46M | -459.06M | -26.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $12.94B | 31.85 | 19.93% | 1.29% | 24.88% | 39.55% | |
74 Outperform | $5.97B | 30.07 | 96.33% | 0.58% | 16.04% | 60.32% | |
73 Outperform | $11.04B | 20.48 | 11.48% | 1.71% | 12.85% | 20.21% | |
72 Outperform | $10.97B | 27.18 | 29.73% | 1.18% | 26.88% | 68.65% | |
71 Outperform | $4.69B | 17.37 | 59.68% | 4.02% | 9.54% | ― | |
67 Neutral | $11.47B | 21.05 | 5.86% | 2.88% | 0.84% | 46.98% | |
67 Neutral | $16.89B | 11.80 | 9.79% | 3.77% | 12.07% | -8.35% |
Houlihan Lokey, Inc. has revised its 2016 Incentive Award Plan, reducing the available shares of common stock to 8 million, effective from October 24, 2024. The share count will further adjust on April 1, 2025, based on specific criteria, potentially impacting stock availability and market dynamics.